The presence of B-cell activating factor (BAFF) in umbilical cord blood in both healthy and pre-eclamptic pregnancies and in human breast milk
• BAFF is present in umbilical cord blood from healthy and pre-eclamptic pregnancies. • BAFF maternal serum levels are lower in pre-eclamptic pregnancies. • BAFF is present in the breast milk up to 180 days post-partum.
Gespeichert in:
| Autor*in: |
Bienertova-Vasku, Julie [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2015 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
5 |
|---|
| Übergeordnetes Werk: |
Enthalten in: The use of serum marker CA-125 in patients operated because of endometriosis - Georgievska, J. ELSEVIER, 2019, the international journal for experimental and clinical reproductive immunobiology, Oxford |
|---|---|
| Übergeordnetes Werk: |
volume:109 ; year:2015 ; pages:89-93 ; extent:5 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jri.2014.12.003 |
|---|
| Katalog-ID: |
ELV012820962 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV012820962 | ||
| 003 | DE-627 | ||
| 005 | 20230623102025.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jri.2014.12.003 |2 doi | |
| 028 | 5 | 2 | |a GBVA2015004000003.pica |
| 035 | |a (DE-627)ELV012820962 | ||
| 035 | |a (ELSEVIER)S0165-0378(14)00162-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 540 |a 610 |q VZ |
| 084 | |a 35.00 |2 bkl | ||
| 084 | |a 44.46 |2 bkl | ||
| 100 | 1 | |a Bienertova-Vasku, Julie |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The presence of B-cell activating factor (BAFF) in umbilical cord blood in both healthy and pre-eclamptic pregnancies and in human breast milk |
| 264 | 1 | |c 2015 | |
| 300 | |a 5 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • BAFF is present in umbilical cord blood from healthy and pre-eclamptic pregnancies. • BAFF maternal serum levels are lower in pre-eclamptic pregnancies. • BAFF is present in the breast milk up to 180 days post-partum. | ||
| 650 | 7 | |a BAFF |2 Elsevier | |
| 650 | 7 | |a Cord blood |2 Elsevier | |
| 650 | 7 | |a Lactation |2 Elsevier | |
| 650 | 7 | |a Pre-eclampsia |2 Elsevier | |
| 650 | 7 | |a Breast milk |2 Elsevier | |
| 700 | 1 | |a Zlamal, Filip |4 oth | |
| 700 | 1 | |a Tomandl, Josef |4 oth | |
| 700 | 1 | |a Hodicka, Zuzana |4 oth | |
| 700 | 1 | |a Novak, Jan |4 oth | |
| 700 | 1 | |a Splichal, Zbynek |4 oth | |
| 700 | 1 | |a Ventruba, Pavel |4 oth | |
| 700 | 1 | |a Thon, Vojtech |4 oth | |
| 700 | 1 | |a Vasku, Anna |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Oxford University Press |a Georgievska, J. ELSEVIER |t The use of serum marker CA-125 in patients operated because of endometriosis |d 2019 |d the international journal for experimental and clinical reproductive immunobiology |g Oxford |w (DE-627)ELV002243032 |
| 773 | 1 | 8 | |g volume:109 |g year:2015 |g pages:89-93 |g extent:5 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jri.2014.12.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 35.00 |j Chemie: Allgemeines |q VZ |
| 936 | b | k | |a 44.46 |j Klinische Pathologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 109 |j 2015 |h 89-93 |g 5 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
j b v jbv |
|---|---|
| matchkey_str |
bienertovavaskujuliezlamalfiliptomandljo:2015----:hpeecobelciaigatrafnmiiacrbodnohelhadrelmtc |
| hierarchy_sort_str |
2015 |
| bklnumber |
35.00 44.46 |
| publishDate |
2015 |
| allfields |
10.1016/j.jri.2014.12.003 doi GBVA2015004000003.pica (DE-627)ELV012820962 (ELSEVIER)S0165-0378(14)00162-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Bienertova-Vasku, Julie verfasserin aut The presence of B-cell activating factor (BAFF) in umbilical cord blood in both healthy and pre-eclamptic pregnancies and in human breast milk 2015 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • BAFF is present in umbilical cord blood from healthy and pre-eclamptic pregnancies. • BAFF maternal serum levels are lower in pre-eclamptic pregnancies. • BAFF is present in the breast milk up to 180 days post-partum. BAFF Elsevier Cord blood Elsevier Lactation Elsevier Pre-eclampsia Elsevier Breast milk Elsevier Zlamal, Filip oth Tomandl, Josef oth Hodicka, Zuzana oth Novak, Jan oth Splichal, Zbynek oth Ventruba, Pavel oth Thon, Vojtech oth Vasku, Anna oth Enthalten in Oxford University Press Georgievska, J. ELSEVIER The use of serum marker CA-125 in patients operated because of endometriosis 2019 the international journal for experimental and clinical reproductive immunobiology Oxford (DE-627)ELV002243032 volume:109 year:2015 pages:89-93 extent:5 https://doi.org/10.1016/j.jri.2014.12.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 44.46 Klinische Pathologie VZ AR 109 2015 89-93 5 045F 610 |
| spelling |
10.1016/j.jri.2014.12.003 doi GBVA2015004000003.pica (DE-627)ELV012820962 (ELSEVIER)S0165-0378(14)00162-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Bienertova-Vasku, Julie verfasserin aut The presence of B-cell activating factor (BAFF) in umbilical cord blood in both healthy and pre-eclamptic pregnancies and in human breast milk 2015 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • BAFF is present in umbilical cord blood from healthy and pre-eclamptic pregnancies. • BAFF maternal serum levels are lower in pre-eclamptic pregnancies. • BAFF is present in the breast milk up to 180 days post-partum. BAFF Elsevier Cord blood Elsevier Lactation Elsevier Pre-eclampsia Elsevier Breast milk Elsevier Zlamal, Filip oth Tomandl, Josef oth Hodicka, Zuzana oth Novak, Jan oth Splichal, Zbynek oth Ventruba, Pavel oth Thon, Vojtech oth Vasku, Anna oth Enthalten in Oxford University Press Georgievska, J. ELSEVIER The use of serum marker CA-125 in patients operated because of endometriosis 2019 the international journal for experimental and clinical reproductive immunobiology Oxford (DE-627)ELV002243032 volume:109 year:2015 pages:89-93 extent:5 https://doi.org/10.1016/j.jri.2014.12.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 44.46 Klinische Pathologie VZ AR 109 2015 89-93 5 045F 610 |
| allfields_unstemmed |
10.1016/j.jri.2014.12.003 doi GBVA2015004000003.pica (DE-627)ELV012820962 (ELSEVIER)S0165-0378(14)00162-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Bienertova-Vasku, Julie verfasserin aut The presence of B-cell activating factor (BAFF) in umbilical cord blood in both healthy and pre-eclamptic pregnancies and in human breast milk 2015 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • BAFF is present in umbilical cord blood from healthy and pre-eclamptic pregnancies. • BAFF maternal serum levels are lower in pre-eclamptic pregnancies. • BAFF is present in the breast milk up to 180 days post-partum. BAFF Elsevier Cord blood Elsevier Lactation Elsevier Pre-eclampsia Elsevier Breast milk Elsevier Zlamal, Filip oth Tomandl, Josef oth Hodicka, Zuzana oth Novak, Jan oth Splichal, Zbynek oth Ventruba, Pavel oth Thon, Vojtech oth Vasku, Anna oth Enthalten in Oxford University Press Georgievska, J. ELSEVIER The use of serum marker CA-125 in patients operated because of endometriosis 2019 the international journal for experimental and clinical reproductive immunobiology Oxford (DE-627)ELV002243032 volume:109 year:2015 pages:89-93 extent:5 https://doi.org/10.1016/j.jri.2014.12.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 44.46 Klinische Pathologie VZ AR 109 2015 89-93 5 045F 610 |
| allfieldsGer |
10.1016/j.jri.2014.12.003 doi GBVA2015004000003.pica (DE-627)ELV012820962 (ELSEVIER)S0165-0378(14)00162-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Bienertova-Vasku, Julie verfasserin aut The presence of B-cell activating factor (BAFF) in umbilical cord blood in both healthy and pre-eclamptic pregnancies and in human breast milk 2015 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • BAFF is present in umbilical cord blood from healthy and pre-eclamptic pregnancies. • BAFF maternal serum levels are lower in pre-eclamptic pregnancies. • BAFF is present in the breast milk up to 180 days post-partum. BAFF Elsevier Cord blood Elsevier Lactation Elsevier Pre-eclampsia Elsevier Breast milk Elsevier Zlamal, Filip oth Tomandl, Josef oth Hodicka, Zuzana oth Novak, Jan oth Splichal, Zbynek oth Ventruba, Pavel oth Thon, Vojtech oth Vasku, Anna oth Enthalten in Oxford University Press Georgievska, J. ELSEVIER The use of serum marker CA-125 in patients operated because of endometriosis 2019 the international journal for experimental and clinical reproductive immunobiology Oxford (DE-627)ELV002243032 volume:109 year:2015 pages:89-93 extent:5 https://doi.org/10.1016/j.jri.2014.12.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 44.46 Klinische Pathologie VZ AR 109 2015 89-93 5 045F 610 |
| allfieldsSound |
10.1016/j.jri.2014.12.003 doi GBVA2015004000003.pica (DE-627)ELV012820962 (ELSEVIER)S0165-0378(14)00162-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Bienertova-Vasku, Julie verfasserin aut The presence of B-cell activating factor (BAFF) in umbilical cord blood in both healthy and pre-eclamptic pregnancies and in human breast milk 2015 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • BAFF is present in umbilical cord blood from healthy and pre-eclamptic pregnancies. • BAFF maternal serum levels are lower in pre-eclamptic pregnancies. • BAFF is present in the breast milk up to 180 days post-partum. BAFF Elsevier Cord blood Elsevier Lactation Elsevier Pre-eclampsia Elsevier Breast milk Elsevier Zlamal, Filip oth Tomandl, Josef oth Hodicka, Zuzana oth Novak, Jan oth Splichal, Zbynek oth Ventruba, Pavel oth Thon, Vojtech oth Vasku, Anna oth Enthalten in Oxford University Press Georgievska, J. ELSEVIER The use of serum marker CA-125 in patients operated because of endometriosis 2019 the international journal for experimental and clinical reproductive immunobiology Oxford (DE-627)ELV002243032 volume:109 year:2015 pages:89-93 extent:5 https://doi.org/10.1016/j.jri.2014.12.003 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 44.46 Klinische Pathologie VZ AR 109 2015 89-93 5 045F 610 |
| language |
English |
| source |
Enthalten in The use of serum marker CA-125 in patients operated because of endometriosis Oxford volume:109 year:2015 pages:89-93 extent:5 |
| sourceStr |
Enthalten in The use of serum marker CA-125 in patients operated because of endometriosis Oxford volume:109 year:2015 pages:89-93 extent:5 |
| format_phy_str_mv |
Article |
| bklname |
Chemie: Allgemeines Klinische Pathologie |
| institution |
findex.gbv.de |
| topic_facet |
BAFF Cord blood Lactation Pre-eclampsia Breast milk |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
The use of serum marker CA-125 in patients operated because of endometriosis |
| authorswithroles_txt_mv |
Bienertova-Vasku, Julie @@aut@@ Zlamal, Filip @@oth@@ Tomandl, Josef @@oth@@ Hodicka, Zuzana @@oth@@ Novak, Jan @@oth@@ Splichal, Zbynek @@oth@@ Ventruba, Pavel @@oth@@ Thon, Vojtech @@oth@@ Vasku, Anna @@oth@@ |
| publishDateDaySort_date |
2015-01-01T00:00:00Z |
| hierarchy_top_id |
ELV002243032 |
| dewey-sort |
3610 |
| id |
ELV012820962 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV012820962</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623102025.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jri.2014.12.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015004000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV012820962</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-0378(14)00162-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.46</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bienertova-Vasku, Julie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The presence of B-cell activating factor (BAFF) in umbilical cord blood in both healthy and pre-eclamptic pregnancies and in human breast milk</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• BAFF is present in umbilical cord blood from healthy and pre-eclamptic pregnancies. • BAFF maternal serum levels are lower in pre-eclamptic pregnancies. • BAFF is present in the breast milk up to 180 days post-partum.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BAFF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cord blood</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lactation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pre-eclampsia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Breast milk</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zlamal, Filip</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tomandl, Josef</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hodicka, Zuzana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Novak, Jan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Splichal, Zbynek</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ventruba, Pavel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thon, Vojtech</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vasku, Anna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Oxford University Press</subfield><subfield code="a">Georgievska, J. ELSEVIER</subfield><subfield code="t">The use of serum marker CA-125 in patients operated because of endometriosis</subfield><subfield code="d">2019</subfield><subfield code="d">the international journal for experimental and clinical reproductive immunobiology</subfield><subfield code="g">Oxford</subfield><subfield code="w">(DE-627)ELV002243032</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:109</subfield><subfield code="g">year:2015</subfield><subfield code="g">pages:89-93</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jri.2014.12.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.46</subfield><subfield code="j">Klinische Pathologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">109</subfield><subfield code="j">2015</subfield><subfield code="h">89-93</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Bienertova-Vasku, Julie |
| spellingShingle |
Bienertova-Vasku, Julie ddc 610 ddc 540 bkl 35.00 bkl 44.46 Elsevier BAFF Elsevier Cord blood Elsevier Lactation Elsevier Pre-eclampsia Elsevier Breast milk The presence of B-cell activating factor (BAFF) in umbilical cord blood in both healthy and pre-eclamptic pregnancies and in human breast milk |
| authorStr |
Bienertova-Vasku, Julie |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV002243032 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl The presence of B-cell activating factor (BAFF) in umbilical cord blood in both healthy and pre-eclamptic pregnancies and in human breast milk BAFF Elsevier Cord blood Elsevier Lactation Elsevier Pre-eclampsia Elsevier Breast milk Elsevier |
| topic |
ddc 610 ddc 540 bkl 35.00 bkl 44.46 Elsevier BAFF Elsevier Cord blood Elsevier Lactation Elsevier Pre-eclampsia Elsevier Breast milk |
| topic_unstemmed |
ddc 610 ddc 540 bkl 35.00 bkl 44.46 Elsevier BAFF Elsevier Cord blood Elsevier Lactation Elsevier Pre-eclampsia Elsevier Breast milk |
| topic_browse |
ddc 610 ddc 540 bkl 35.00 bkl 44.46 Elsevier BAFF Elsevier Cord blood Elsevier Lactation Elsevier Pre-eclampsia Elsevier Breast milk |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
f z fz j t jt z h zh j n jn z s zs p v pv v t vt a v av |
| hierarchy_parent_title |
The use of serum marker CA-125 in patients operated because of endometriosis |
| hierarchy_parent_id |
ELV002243032 |
| dewey-tens |
610 - Medicine & health 540 - Chemistry |
| hierarchy_top_title |
The use of serum marker CA-125 in patients operated because of endometriosis |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV002243032 |
| title |
The presence of B-cell activating factor (BAFF) in umbilical cord blood in both healthy and pre-eclamptic pregnancies and in human breast milk |
| ctrlnum |
(DE-627)ELV012820962 (ELSEVIER)S0165-0378(14)00162-4 |
| title_full |
The presence of B-cell activating factor (BAFF) in umbilical cord blood in both healthy and pre-eclamptic pregnancies and in human breast milk |
| author_sort |
Bienertova-Vasku, Julie |
| journal |
The use of serum marker CA-125 in patients operated because of endometriosis |
| journalStr |
The use of serum marker CA-125 in patients operated because of endometriosis |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
zzz |
| container_start_page |
89 |
| author_browse |
Bienertova-Vasku, Julie |
| container_volume |
109 |
| physical |
5 |
| class |
610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Bienertova-Vasku, Julie |
| doi_str_mv |
10.1016/j.jri.2014.12.003 |
| dewey-full |
610 540 |
| title_sort |
presence of b-cell activating factor (baff) in umbilical cord blood in both healthy and pre-eclamptic pregnancies and in human breast milk |
| title_auth |
The presence of B-cell activating factor (BAFF) in umbilical cord blood in both healthy and pre-eclamptic pregnancies and in human breast milk |
| abstract |
• BAFF is present in umbilical cord blood from healthy and pre-eclamptic pregnancies. • BAFF maternal serum levels are lower in pre-eclamptic pregnancies. • BAFF is present in the breast milk up to 180 days post-partum. |
| abstractGer |
• BAFF is present in umbilical cord blood from healthy and pre-eclamptic pregnancies. • BAFF maternal serum levels are lower in pre-eclamptic pregnancies. • BAFF is present in the breast milk up to 180 days post-partum. |
| abstract_unstemmed |
• BAFF is present in umbilical cord blood from healthy and pre-eclamptic pregnancies. • BAFF maternal serum levels are lower in pre-eclamptic pregnancies. • BAFF is present in the breast milk up to 180 days post-partum. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
The presence of B-cell activating factor (BAFF) in umbilical cord blood in both healthy and pre-eclamptic pregnancies and in human breast milk |
| url |
https://doi.org/10.1016/j.jri.2014.12.003 |
| remote_bool |
true |
| author2 |
Zlamal, Filip Tomandl, Josef Hodicka, Zuzana Novak, Jan Splichal, Zbynek Ventruba, Pavel Thon, Vojtech Vasku, Anna |
| author2Str |
Zlamal, Filip Tomandl, Josef Hodicka, Zuzana Novak, Jan Splichal, Zbynek Ventruba, Pavel Thon, Vojtech Vasku, Anna |
| ppnlink |
ELV002243032 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.jri.2014.12.003 |
| up_date |
2024-07-06T17:16:23.609Z |
| _version_ |
1803850805267136512 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV012820962</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623102025.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jri.2014.12.003</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015004000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV012820962</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-0378(14)00162-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.46</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bienertova-Vasku, Julie</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The presence of B-cell activating factor (BAFF) in umbilical cord blood in both healthy and pre-eclamptic pregnancies and in human breast milk</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• BAFF is present in umbilical cord blood from healthy and pre-eclamptic pregnancies. • BAFF maternal serum levels are lower in pre-eclamptic pregnancies. • BAFF is present in the breast milk up to 180 days post-partum.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BAFF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cord blood</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lactation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pre-eclampsia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Breast milk</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zlamal, Filip</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tomandl, Josef</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hodicka, Zuzana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Novak, Jan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Splichal, Zbynek</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ventruba, Pavel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thon, Vojtech</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vasku, Anna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Oxford University Press</subfield><subfield code="a">Georgievska, J. ELSEVIER</subfield><subfield code="t">The use of serum marker CA-125 in patients operated because of endometriosis</subfield><subfield code="d">2019</subfield><subfield code="d">the international journal for experimental and clinical reproductive immunobiology</subfield><subfield code="g">Oxford</subfield><subfield code="w">(DE-627)ELV002243032</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:109</subfield><subfield code="g">year:2015</subfield><subfield code="g">pages:89-93</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jri.2014.12.003</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.46</subfield><subfield code="j">Klinische Pathologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">109</subfield><subfield code="j">2015</subfield><subfield code="h">89-93</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.399748 |